X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (3) 3
arthritis, rheumatoid - drug therapy (3) 3
female (3) 3
humans (3) 3
index medicus (3) 3
male (3) 3
middle aged (3) 3
rheumatoid arthritis (3) 3
rheumatology (3) 3
antirheumatic agents - therapeutic use (2) 2
arthritis (2) 2
retrospective studies (2) 2
rheumatoid factor (2) 2
rheumatoid-arthritis (2) 2
tocilizumab (2) 2
abatacept (1) 1
abatacept - administration & dosage (1) 1
abatacept - adverse effects (1) 1
abatacept - therapeutic use (1) 1
active ankylosing-spondylitis (1) 1
adalimumab (1) 1
adherence (1) 1
administration route (1) 1
adolescent (1) 1
adult (1) 1
adverse events (1) 1
aged, 80 and over (1) 1
analysis (1) 1
antagonistes du tnf-α (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antirheumatic agents - administration & dosage (1) 1
antirheumatic agents - adverse effects (1) 1
arthritis, juvenile - drug therapy (1) 1
arthritis, juvenile - epidemiology (1) 1
arthritis, psoriatic - drug therapy (1) 1
arthritis, psoriatic - epidemiology (1) 1
arthritis, rheumatoid - blood (1) 1
arthritis, rheumatoid - diagnosis (1) 1
arthritis, rheumatoid - epidemiology (1) 1
arthritis, rheumatoid - immunology (1) 1
autonomy (1) 1
biological products - adverse effects (1) 1
biological products - therapeutic use (1) 1
biologics (1) 1
biologics failure (1) 1
biomarkers - blood (1) 1
blood (1) 1
blood sedimentation (1) 1
c-reactive protein (1) 1
c-reactive protein - metabolism (1) 1
cancer (1) 1
child (1) 1
colitis, ulcerative - chemically induced (1) 1
colitis, ulcerative - epidemiology (1) 1
comparative analysis (1) 1
controlled-trial (1) 1
crohn disease - chemically induced (1) 1
crohn disease - epidemiology (1) 1
crohn's disease (1) 1
crohns-disease (1) 1
cross-sectional studies (1) 1
double-blind (1) 1
drug substitution (1) 1
effet paradoxal (1) 1
efficacy (1) 1
etanercept (1) 1
eular recommendations (1) 1
fear (1) 1
follow-up studies (1) 1
france (1) 1
france - epidemiology (1) 1
il-6 receptor (1) 1
immunoglobulin g - therapeutic use (1) 1
inadequate response (1) 1
incidence (1) 1
inflammatory bowel disease (1) 1
inflammatory bowel diseases - chemically induced (1) 1
inflammatory bowel diseases - epidemiology (1) 1
infliximab (1) 1
infusions, intravenous (1) 1
injection (1) 1
injections, subcutaneous (1) 1
internal medicine (1) 1
intravenous administration (1) 1
inventories (1) 1
juvenile idiopathic arthritis (1) 1
life sciences (1) 1
maladie de crohn (1) 1
maladie inflammatoire intestinale (1) 1
medical examination (1) 1
medical research (1) 1
medicine, experimental (1) 1
necrosis-factor-alpha (1) 1
new-onset (1) 1
original research (1) 1
paradoxical effect (1) 1
patient preference - statistics & numerical data (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Joint Bone Spine, ISSN 1297-319X, 2011, Volume 79, Issue 5, pp. 457 - 463
Abstract Objectives To describe cases of new onset of inflammatory bowel disease (IBD) in patients with inflammatory rheumatic disease (IRD) receiving... 
Internal Medicine | Rheumatology | Inflammatory bowel disease | TNF-α antagonists | Crohn's disease | Paradoxical effect | CONTROLLED-TRIAL | CROHNS-DISEASE | JUVENILE IDIOPATHIC ARTHRITIS | NEW-ONSET | NECROSIS-FACTOR-ALPHA | RHEUMATOLOGY | ACTIVE ANKYLOSING-SPONDYLITIS | TNF-alpha antagonists | ETANERCEPT | INFLIXIMAB | SPONDYLOARTHROPATHIES | ADVERSE EVENTS | Crohn Disease - epidemiology | Arthritis, Psoriatic - epidemiology | Rheumatic Diseases - drug therapy | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Colitis, Ulcerative - epidemiology | Arthritis, Juvenile - drug therapy | Incidence | Receptors, Tumor Necrosis Factor - therapeutic use | Young Adult | Rheumatic Diseases - epidemiology | Inflammatory Bowel Diseases - epidemiology | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Crohn Disease - chemically induced | Arthritis, Psoriatic - drug therapy | Spondylitis, Ankylosing - epidemiology | Aged, 80 and over | Adult | Female | Inflammatory Bowel Diseases - chemically induced | Retrospective Studies | Arthritis, Juvenile - epidemiology | Child | Antirheumatic Agents - therapeutic use | France - epidemiology | Spondylitis, Ankylosing - drug therapy | Arthritis, Rheumatoid - epidemiology | Immunoglobulin G - therapeutic use | Colitis, Ulcerative - chemically induced | Adolescent | Aged | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus | Life Sciences | Cancer
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 07/2012, Volume 79, Issue 4, pp. 323 - 329
Décrire les cas de patients développant une maladie inflammatoire intestinale (MICI) dans un contexte de rhumatisme inflammatoire (RI) traité par agents... 
Antagonistes du TNF-α | Effet paradoxal | Maladie de Crohn | Maladie inflammatoire intestinale
Journal Article
International Journal of Rheumatic Diseases, ISSN 1756-1841, 11/2016, Volume 19, Issue 11, pp. 1093 - 1102
Journal Article
Rheumatology and therapy, ISSN 2198-6576, 01/2019, Volume 6, Issue 1, pp. 61 - 75
The main objective of this work was to assess the maintenance of effectiveness of subcutaneous tocilizumab 6 months after switching from intravenous to... 
Rheumatoid arthritis
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 11/2014, Volume 81, pp. A388 - A400
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.